Probability of relapse according to Q-PCR category. Patients in this study who met criteria for MR whose prior pattern of molecular monitoring could be assessed were considered in conjunction with patients in the same molecular remission category who did not relapse. It was possible thereby to derive projected risks of relapse for patients in each category. The respective risks in the 3 categories were significantly different (P = .009).